<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00753389</url>
  </required_header>
  <id_info>
    <org_study_id>PORC_main</org_study_id>
    <nct_id>NCT00753389</nct_id>
  </id_info>
  <brief_title>Muscle Relaxants and Post-Anesthesia Complications</brief_title>
  <acronym>PORC</acronym>
  <official_title>Epidemiologic Study on Short and Long-Term Effects of Anesthesia With Muscle Relaxants (Epidemiologische Untersuchung Kurz- Und längerfristiger Auswirkungen Der Anästhesie Mit Muskelrelaxanzien)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universität München</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Technische Universität München</source>
  <brief_summary>
    <textblock>
      This Germany-wide, multi-center, epidemiologic study is designed to evaluate the incidence of&#xD;
      post-operative/anesthesia effects of muscle relaxants (i.e. post-operative residual&#xD;
      curarization: PORC) and their effect on patient outcome. Aside from biometric data, type of&#xD;
      operation, use of muscle relaxants and neuromuscular monitoring, all patients will be&#xD;
      clinically evaluated after their operation in the post-anesthesia care unit. To look at&#xD;
      long-term effects, patients will be followed-up 28 days after their operation/anesthesia&#xD;
      regarding post-operative/anesthesia morbidity and mortality.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Muscle relaxants are integral part of modern anesthesia. They optimize intubating conditions,&#xD;
      reduce laryngeal trauma and improve operating conditions. Drawback is a possible&#xD;
      pharmacological (muscle relaxing) effect of these drugs beyond the end of the operation (i.e.&#xD;
      post-operative residual curarization: PORC). PORC is a relevant complication after general&#xD;
      anesthesia. Reportedly about 30% of all patients who received muscle relaxants show signs of&#xD;
      PORC when arriving in the post-anesthesia care unit. PORC comprises the risk of impaired&#xD;
      post-operative fine motor and coordinative skills with a possible impairment of swallowing&#xD;
      pharyngeal secretions with an increased risk of aspiration after extubation. Possible&#xD;
      deleterious effects of this could be pneumonia, bronchitis, myocardial infarction, cardiac&#xD;
      insufficiency, stoke or re-operation. In a pilot study we were able to identify clinical&#xD;
      assessment criteria to assess patients' risk for aspiration, which are now part of the&#xD;
      post-anesthesia evaluation of every patient.&#xD;
&#xD;
      Unfortunately there is a major pitfall arising from the inability to clearly identify PORC.&#xD;
      Although objective neuromuscular monitoring is the golden standard to measure neuromuscular&#xD;
      transmission during anesthesia, clinical signs have been used to identify muscle weakness&#xD;
      postoperatively. One reason for this practice is the varying action of muscle relaxants at&#xD;
      different muscle groups demonstrating neuromuscular monitoring to be insufficiently sensitive&#xD;
      to detect PORC symptoms at the pharyngeal muscles. This situation may lead to a seldom use of&#xD;
      neuromuscular monitoring devices and may add to a decreasing use of muscle relaxants in&#xD;
      clinical anesthesia.&#xD;
&#xD;
      In this Germany-wide, multi-center, epidemiologic study we would like to evaluate if the use&#xD;
      of muscle relaxants, or signs of their prolonged effect beyond the end of the&#xD;
      operation/anesthesia (PORC), affect the further in-hospital stay and post-operative morbidity&#xD;
      and mortality. The sampling in 8 German hospitals should determine the number of patients&#xD;
      with clinically relevant signs of muscle weakness at the time of arrival in the&#xD;
      post-anesthesia care unit. Therefore a data entry form has been developed by the principal&#xD;
      and sub-investigators of the 8 participating study hospitals. This data entry form enables&#xD;
      the staff in charge of the post-anesthesia care unit to acquire and to document residual&#xD;
      neuromuscular blockades. The sampling will be done in the 8 participating hospitals on 21&#xD;
      randomized working days over a period of 24 hours. To identify the potential risk factors for&#xD;
      postoperative residual curarization, the known predictors for neuromuscular rest blockades&#xD;
      are recorded as well. Known predictors are for example: type and amount of muscle relaxant,&#xD;
      duration of operation and anesthesia, surgical procedure, patients' age,&#xD;
      anesthesia-technique, antagonization of muscle relaxant or neuromuscular monitoring. Further,&#xD;
      the patients' progress in the post-anesthesia care unit is documented.&#xD;
&#xD;
      The 28 day outcome of patients is followed up with a second data entry form which includes&#xD;
      health-economical aspects. Reported are complications, duration of intensive care unit and&#xD;
      hospital stay, as well as remaining health damages at the time of discharge. To estimate the&#xD;
      significance of PORC, data of patients with PORC is compared to data of patients without&#xD;
      PORC. These patients are recruited during the first data collection period in the&#xD;
      post-anesthesia care unit. The control for any patient with PORC is the next one arriving in&#xD;
      the post-anesthesia care unit without PORC.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2008</start_date>
  <completion_date type="Anticipated">March 2009</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival</measure>
    <time_frame>28 days after anesthesia</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20000</enrollment>
  <condition>Postoperative Residual Curarization</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>None (anesthesia)</intervention_name>
    <description>anesthesia</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients receiving anesthesia&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients attended by an anesthesiologist&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  none&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manfred Prof.Dr. Blobner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinik für Anaesthesiologie, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Str. 22, 81675 München</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Manfred Prof.Dr. Blobner, MD</last_name>
    <phone>0894140</phone>
    <phone_ext>7206</phone_ext>
    <email>Blobner@lrz.tum.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Heidrun Dr. Fink, MD</last_name>
    <phone>0894140</phone>
    <phone_ext>6289</phone_ext>
    <email>h.fink@lrz.tum.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Klinik für Anaesthesiologie, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Str. 22</name>
      <address>
        <city>München</city>
        <state>Bavaria</state>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manfred Prof. Dr. Blobner, MD</last_name>
      <phone>+49894140</phone>
      <phone_ext>7206</phone_ext>
      <email>Blobner@lrz.tum.de</email>
    </contact>
    <contact_backup>
      <last_name>Heidrun Dr. Fink, MD</last_name>
      <phone>+49894140</phone>
      <phone_ext>6289</phone_ext>
      <email>h.fink@lrz.tum.de</email>
    </contact_backup>
    <investigator>
      <last_name>Manfred Prof. Blobner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Götz Prof. Geldner, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gabriele Prof. Nölge- Schomburg, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Prof. Standl, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hugo Prof. van Aken, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Friedrich Prof. Pühringer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jens Prof. Scholz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexander PD. Dr. Schleppers, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2008</verification_date>
  <study_first_submitted>September 15, 2008</study_first_submitted>
  <study_first_submitted_qc>September 15, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2008</study_first_posted>
  <last_update_submitted>September 15, 2008</last_update_submitted>
  <last_update_submitted_qc>September 15, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 16, 2008</last_update_posted>
  <responsible_party>
    <name_title>Prof. Dr. Manfred Blobner</name_title>
    <organization>Klinik für Anaesthesiologie, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Str. 22, 81675 München</organization>
  </responsible_party>
  <keyword>Postoperative residual curarization,</keyword>
  <keyword>muscle relaxants,</keyword>
  <keyword>morbidity mortality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Hypotonia</mesh_term>
    <mesh_term>Delayed Emergence from Anesthesia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

